<DOC>
	<DOCNO>NCT00305578</DOCNO>
	<brief_summary>The purpose study investigate whether addition memantine bipolar depression patient incomplete response lamotrigine ( Lamictal ) frequently use treat bipolar depression clinical setting . At present , memantine approve use treatment Alzheimer 's disease dementia , use treatment bipolar depression . Subjects ask participate suffering bipolar depression associate inadequate response lamotrigine . Subjects least 100 mg per day , least 4 week .</brief_summary>
	<brief_title>Memantine Augmentation Lamotrigine Incomplete-Response Bipolar Depression</brief_title>
	<detailed_description>Hypothesis/Objectives : H1 : Lamotrigine inadequate-response patient augment memantine 8 week significantly great improvement Hamilton Depression Rating Scale ( HDRS ) Clinical Global Improvement ( CGI ) scale compare patient augment placebo . H2 : Lamotrigine inadequate-response patient augment memantine 8 week significantly great improvement score Selective Reminding Test ( SRT ) , Digit Span Test , Stroop Test , Trail Making Test ( TMT ) patient augment placebo . Study Population : We study 40 bipolar disorder depress ( BDD ) outpatient ( 20 arm ) recruit outpatient Mood Disorders Clinic advertisement .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>: 1 ) age 18 65 ; 2 ) satisfy DSMIVTR criterion Bipolar Disorder Major Depressive Episode ; 3 ) Lamotrigine InadequateResponse : Defined already treat least 100 mg lamotrigine least 4 week 17 item HDRS rating &gt; 15 ; 4 ) give informed consent approve local IRB ; 5 ) antidepressant mood stabilizer stable dose past 4 week . 1 ) comorbid psychotic disorder schizophrenia schizoaffective disorder ; 2 ) significant suicidal homicidal risk ; 3 ) clinically significant medical illness ; 4 ) allergy intolerance lamotrigine memantine ; 5 ) pregnancy , plan pregnant use adequate contraception ; 6 ) satisfy criterion substance dependence within 6 month prior start study ; 7 ) medication significant adverse interaction either lamotrigine memantine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Bipolar</keyword>
	<keyword>Depression</keyword>
	<keyword>Incomplete Response</keyword>
</DOC>